BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stryker Launches Next Generation Trevo® ProVue™ Retrieval System


11/9/2012 9:47:10 AM

KALAMAZOO, Mich., Nov. 8, 2012 /PRNewswire/ -- Stryker announced today the global commercial launch of the new Trevo® ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device.

(Photo: http://photos.prnewswire.com/prnh/20121108/PH09237 )

"Trevo ProVue Retriever's full visibility provides a significant clinical benefit," said Professor Liebig, M.D., Head of Neuroradiology, University Hospital of Cologne in Cologne, Germany. "I am impressed with how full device visibility provides more information during the procedure to quickly and easily position the device and enables real-time feedback for a new level of confidence to open blood vessels."

Oregon Health & Science University (OHSU) was the institution where the first patient in the United States was treated using the Trevo® ProVue Retriever. "It is of great benefit to be able to see how a device interacts with the clot within the vessel, and may be able to demonstrate an underlying stenosis, as it did in the first patient we treated with the device," said Gary Nesbit, M.D., Professor of Neuroradiology, Neurology, Neurosurgery, and the Dotter Interventional Institute at OHSU. "This gives me better information for clinical decisions and potentially increases the chance for better outcomes for my patients."

"Trevo ProVue represents our dedication to providing patients and physicians with the most advanced tools available to treat acute ischemic stroke," said Mark Paul, President of Stryker's Neurovascular division. "Trevo ProVue sets a new standard in stent retriever technology. It's the first fully visible device allowing physicians to visualize placement, clot interaction and retrieval that can make a big difference in patient treatment."

The Trevo® ProVue Retriever is supported by robust clinical evidence from the Trevo® family of Retrievers in the TREVO and TREVO 2 clinical trials, which demonstrated high revascularization and improved clinical outcomes compared to the first generation Merci Retriever®. The device has been granted 510(k) market clearance by the U.S. Food and Drug Administration and is also available in international markets where it has been cleared for sale.

View an animation of the Trevo® ProVue Retriever on Stryker's YouTube channel.

About Stryker

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

Media Contact:
Joe Cooper
Stryker Corporation
(201) 831-6220
joe.cooper@stryker.com

Investor Contact:
Katherine Owen
Stryker Corporation
(269) 385-2600
katherine.owen@stryker.com

SOURCE Stryker



Read at BioSpace.com

Stryker
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES